Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Early Detection
AddedFeb 18, 2024
UpdatedJun 18, 2026
Early Detection

Early Detection

Seed

Early Detection, founded in 2017, develops non-invasive, accurate cancer screening tests in San Diego.

HQ
San Diego, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Early Detection, founded in 2017 by Kim Vanderlinden, Gary McAdam, and AbulKalam Shamsuddin, is a San Diego-based company focused on revolutionizing cancer screening. Their core mission is to transform how doctors and patients detect and defeat cancer through non-invasive, accurate tests. The company’s flagship product, EarlyTest, aims to enable point-of-care cancer detection at all stages and assess future cancer risks directly in a doctor's office, significantly improving patient survival rates.

Notable figures affiliated with Early Detection include its founders, who bring extensive expertise in medical research and technology. The company has garnered attention for its innovative approach to cancer screening, potentially setting new standards in early detection. By providing accessible and reliable testing methods, Early Detection is poised to make a substantial impact on public health, aiming to save lives through earlier diagnosis and treatment of cancer.

Early Detection - Similar Companies

Thrive Earlier Detection logo

Thrive Earlier Detection

Oncodea logo

Oncodea

oncodea.com

Exact Sciences logo

Exact Sciences

exactsciences.com

Early is Good logo

Early is Good

earlyisgood.com

Pharus Diagnostics logo

Pharus Diagnostics

pharusdx.com

GRAIL logo

GRAIL

grail.com

Freenome logo

Freenome

freenome.com

Earli logo

Earli

earli.com

Cellens logo

Cellens

cellensinc.com

Harbinger Health logo

Harbinger Health

Oncotect logo

Oncotect

oncotect.co

Cleveland Diagnostics logo

Cleveland Diagnostics

clevelanddx.com

Promiss Diagnostics logo

Promiss Diagnostics

promissdx.com

Lucence logo

Lucence

lucence.com

Avant Diagnostics logo

Avant Diagnostics

Early Detection - Quick Facts

Who are Early Detection's competitors?

Companies similar to Early Detection include Thrive Earlier Detection, Oncodea, Exact Sciences and Early is Good.

When was Early Detection founded?

Early Detection was founded in 2017.

Where is Early Detection's headquarters located?

Early Detection's headquarters is located in San Diego, CA, US.

When was Early Detection's last funding round?

Early Detection's most recent funding round was for $25k (USD) in March 2023.

How much has Early Detection raised to-date?

As of Mar 16, 2023, Early Detection has raised a total of $282k (USD).

How many employees does Early Detection have?

Early Detection has 7 employees as of Feb 5, 2024.

Early Detection - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Main Product
  • Cancerscreening
Tags
  • Enterprise Consumers
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified